AH1 Sequence (6-14) murine leukemia virus MuLV – 1 mg

Overview

The AH1 Sequence (6-14) murine leukemia virus MuLV is an essential peptide for researchers studying the immune response to retroviral infections. This specific epitope, known as the H2-Ld-restricted epitope derived from gp-70, is critical in immunological studies involving CT26 colon carcinoma cells and various tumor cell lines. Whether you’re developing assay kits or exploring neurological markers, the AH1 Sequence can enhance your research methodology.

Key Features

• Derived from the endogenous retroviral gene product envelope glycoprotein 70
• H2-Ld-restricted epitope crucial for immune response studies
• Compatible with numerous tumor cell lines
• Available in a convenient 1 mg quantity for easy use in experiments
• Supports a broad range of applications in research and diagnostics

Specifications

FAQ

What is the significance of the AH1 Sequence?

The AH1 sequence is an important peptide for studying immune responses in murine models, particularly in the context of cancer and infectious diseases.

Can I use the AH1 Sequence for my research on other tumors?

Yes, this peptide is expressed in various tumor cell lines, making it versatile for a range of studies.

How should I store the AH1 Sequence?

Store the peptide at -20°C to maintain stability and ensure optimal performance in assays.

If you’re looking to enhance your research with the AH1 Sequence (6-14), now is the time to buy. It’s for sale and ready to support your projects in understanding tumor immunology and retroviral interactions. Check out our selection of peptides for more options that could complement your experiments.

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled